TEAD4 and ovarian neoplasm: Active TEAD4-binding sites (coinciding with H3K27ac ChIP-seq OC peaks) were significantly mutated in ovarian tumors (fold change (FC)(obs/exp) = 1.8, P = 6 × 10−11) (Fig. 3j).